Literature DB >> 14530014

Is extended arch replacement for acute type a aortic dissection an additional risk factor for mortality?

M Erwin S H Tan1, Karl M E Dossche, Wim J Morshuis, Johannes C Kelder, Frans G J Waanders, Marc A A M Schepens.   

Abstract

BACKGROUND: We report our experience with surgery for acute type A aortic dissection with involvement of the aortic arch.
METHODS: From January 1986 to December 2001, 277 patients underwent surgery for acute type A aortic dissection. In 70 patients (25.3%), surgery was extended into the aortic arch: hemiarch and total arch replacement in 53 (75.7%) and 17 (24.3%) patients, respectively. Deep hypothermic circulatory arrest was used in 19 patients, antegrade selective cerebral perfusion in 38, and combined deep hypothermic circulatory arrest with antegrade selective cerebral perfusion in 13.
RESULTS: Operative mortality was 18.6% (13/70) after extended replacement into the arch versus 21.7% (45/207) after surgery limited to the ascending aorta (p = 0.62). Multivariate analysis did not reveal significant risk factors for operative mortality. Postoperatively, 5 patients (8.1%) had a new postoperative cerebral vascular accident (CVA). Multivariate analysis showed an earlier date of operation as the only independent determinant for a new postoperative CVA (p = 0.0162, RR = 0.80/year, 95% CI = 0.67 to 0.96). None of the patients, operated on with antegrade selective cerebral perfusion, had a new cerebral deficit. Comparing the different methods of cerebral protection, multivariate risk analysis revealed antegrade selective cerebral perfusion as a significant protective factor against new postoperative CVA (p = 0.0110, OR = 0.12, 95% CI = 0.02 to 0.61). Survival at 5 and 10 years was 66.6.5% and 40.0%, respectively, after replacement of the aortic arch versus 68.7% and 57.7%, respectively, after replacement of the ascending aorta (p = 0.96). Freedom from aortic arch reoperation was 96.3% at 5 and 77.0% at 10 years versus 86.6% and 75.1% in both groups, respectively (p = 0.21).
CONCLUSIONS: Extended replacement into the aortic arch during surgery for acute type A dissection does not influence early and late results. The best cerebral protection seems to be obtained with antegrade selective cerebral perfusion.

Entities:  

Mesh:

Year:  2003        PMID: 14530014     DOI: 10.1016/s0003-4975(03)00726-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Hemiarch versus total aortic arch replacement in acute type A dissection: a systematic review and meta-analysis.

Authors:  Shi Sum Poon; Thomas Theologou; Deborah Harrington; Manoj Kuduvalli; Aung Oo; Mark Field
Journal:  Ann Cardiothorac Surg       Date:  2016-05

2.  A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion.

Authors:  David H Tian; Benjamin Wan; Paul G Bannon; Martin Misfeld; Scott A LeMaire; Teruhisa Kazui; Nicholas T Kouchoukos; John A Elefteriades; Joseph Bavaria; Joseph S Coselli; Randall B Griepp; Friedrich W Mohr; Aung Oo; Lars G Svensson; G Chad Hughes; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2013-03

3.  Early and mid-term outcomes of the aortic arch surgery: experience from the low-volume centre.

Authors:  Radim Brat; Jaroslav Gaj; Jiri Barta
Journal:  J Cardiothorac Surg       Date:  2015-03-10       Impact factor: 1.637

4.  Extensive aortic surgery in acute aortic dissection type A on outcome - insights from 25 years single center experience.

Authors:  Bashar Dib; Philipp Christian Seppelt; Rawa Arif; Alexander Weymann; Gábor Veres; Bastian Schmack; Carsten J Beller; Arjang Ruhparwar; Matthias Karck; Klaus Kallenbach
Journal:  J Cardiothorac Surg       Date:  2019-11-06       Impact factor: 1.637

5.  A Clinical Analysis of Thirty-Five Patients Undergoing Aortic Reoperation.

Authors:  Xin Yuanfeng; Jian Kaitao; Safwa Mahmood; Liu Jianshi; Sun Lizhong; He Yaping; Liu Wei
Journal:  Braz J Cardiovasc Surg       Date:  2022-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.